Bentham Science Logo

Current Pharmaceutical Biotechnology

Volume 20, 15 Issues, 2019
ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)
This journal supports open access

Ranking and Category

  • 259th of 298 in

    Biochemistry & Molecular Biology

  • 219th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Aims & Scope

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth/mini reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include:

  • DNA/protein engineering and processing
  • Synthetic biotechnology
  • Omics (genomics, proteomics, metabolomics and systems biology)
  • Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)
  • Drug delivery and targeting
  • Nanobiotechnology
  • Molecular pharmaceutics and molecular pharmacology
  • Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)
  • Pharmacokinetics and pharmacodynamics
  • Applied Microbiology
  • Bioinformatics (computational biopharmaceutics and modeling)
  • Environmental biotechnology
  • Regenerative medicine (stem cells, tissue engineering and biomaterials)
  • Translational immunology (cell therapies, antibody engineering, xenotransplantation)
  • Industrial bioprocesses for drug production and development
  • Biosafety
  • Biotech ethics

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.

Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Current Pharmaceutical Biotechnology

,

Volume 20

-

Number 9



Biography   Open Access



Review Article



Review Article



Research Article



Research Article



Research Article

Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study

, 20(9): 727 - 732

Konrad Dziobek*, Marcin Opławski, Beniamin Grabarek, Nikola Zmarzły, Robert Kiełbasiński, Ewa Leśniak, Piotr Januszyk, Krzysztof Januszyk, Iwona Adwent, Dariusz Dąbruś, Przemysław Kieszkowski, Kamil Kiełbasiński, Agnieszka Kuś-Kierach and Dariusz Boroń


DOI: 10.2174/1389201020666190619145655


Research Article

Simvastatin and ML141 Decrease Intracellular Streptococcus pyogenes Infection

, 20(9): 733 - 744

Lindy Caffo, Bria L. Sneed, Caroline Burcham, Katie Reed, Nathan C. Hahn, Samantha Bell, Olivia Downham, Melissa D. Evans, Christopher R. Fullenkamp, Teague K. Drinnon, Derron Bishop, Heather A. Bruns, John L. McKillip, Robert E. Sammelson and Susan A. McDowell*


DOI: 10.2174/1389201020666190618115154


Research Article

The Ultrashort Peptide OW: A New Antibiotic Adjuvant

, 20(9): 745 - 754

Yara Al Tall*, Ahmad Abualhaijaa, Mohammed T. Qaoud, Mohammad Alsaggar, Majed Masadeh and Karem H. Alzoubi


DOI: 10.2174/1389201020666190618111252


Current Pharmaceutical Biotechnology, Volume 20 (2019) - Number 12


This issue is in progress but contains articles that are final and fully citable.

Current Pharmaceutical Biotechnology, Volume 20 (2019) - Number 11


This issue is in progress but contains articles that are final and fully citable.

Current Pharmaceutical Biotechnology, Volume 20 (2019) - Number 10


This issue is in progress but contains articles that are final and fully citable.

Articles Ahead of Print






Ethnobotany and Pharmacology of Pinus Species Growing Naturally in Indian Himalayas: A Plant Review


Lav Singh, Pooja Dixit, Ravi Prakash Srivastava, Shivaraman Pandey, Praveen Chandra Verma and Gauri Saxena*


DOI: 10.2174/1389201020666190819153600
View Abstract View on PubMed


Are Viruses and Parasites Linked to Celiac Disease? A Question that Still has no Definite Answer


Aref Shariati, Hamid Reza Aslani, Mohammad Reza Hooshangi Shayesteh, Ali Taghipour, Ahmad Nasser, Hossein Safari, Mahmood Alizade-Sani, Amin Dehghan and Taher Azimi*


DOI: 10.2174/1389201020666190828124924
View Abstract View on PubMed


Preparation of Chitosan/Alginate-ellagic Acid Sustained-release Microspheres and their Inhibition of Preadipocyte Adipogenic Differentiation


Chengshi Ding, Deya Wang, Haidan Bi, Meiling Kang, Zhongjing Tian, Yingxia Zhang, Hongkai Wang, Jing Ma* and Tianshun Zhu*


DOI: 10.2174/1389201020666190809110511
View Abstract


Coffea arabica Bean Extracts and Vitamin C: A Novel Combination Unleashes MCF-7 Cell Death


Islam El-Garawani*, Sobhy Hassab El-Nabi, Samraa El-Safey, Mohamed Elfiky and Ebtesam Nafie


DOI: 10.2174/1389201020666190822161337
View Abstract View on PubMed



Abstracts Ahead of Print

Assessment of immunohistochemical expression of SEMA5A as a molecular marker in endometrial cancer


Konrad Dziobek*, Marcin Opławski, Beniamin Oskar Grabarek, Nikola Zmarzły, Przemysław Kieszkowski, Piotr Januszyk, Kamil Kiełbasiński, Robert Kiełbasiński and Dariusz Boroń


DOI: 10.2174/1389201020666190911113611
View Abstract


Variances in the level of of COX-2 and iNOS in different grades of endometrial cancer


Marcin Oplawski*, Konrad Dziobek, Nikola Zmarzły, Beniamin Grabarek, Robert Kiełbasiński, Przemysław Kieszkowski, Piotr Januszyk, Karol Talkowski, Andrzej Plewka and Dariusz Boroń


DOI: 10.2174/1389201020666190918104105
View Abstract


The In Vitro Anti-Cancer Activities of 17βH-Neriifolin Isolated from Cerbera odollam and Its Binding Activity on Na+,K+-ATPase


Nurhanan Murni Yunos*, Asiah Osman, Muhammad Haffiz Jauri, Nor Jannah Sallehudin and Siti Syarifah Mohd Mutalip


DOI: 10.2174/1389201020666190917154850
View Abstract





Published Contents

Drs. Eric Betzig, Stefan W. Hell and William E. Moerner share the 2014 chemistry Nobel for the development of super-resolved fluorescence microscopy.

“The Royal Swedish Academy of Sciences has decided to award the 2014 Nobel Prize in Chemistry to Dr. Eric Betzig at Howard Hughes Medical Institute, Ashburn, U.S.A.; Professor Stefan Hell at Max Planck Institute for Biophysical Chemistry, Göttingen, and the German Cancer Research Center, Heidelberg, Germany; and Professor William Moerner at Stanford University, Stanford, U.S.A., for the development of super-resolved fluorescence microscopy.”

Much research effort was needed to realize that single-cell and single-molecule based approaches directly affect improvements in human health. However, many of these laboratory technologies are not available in a cheap and easy version. Single-molecule based fluorescence imaging and detection have the advantages of a small volume platform, digital analysis, elimination of processing steps, real-time measurements and automation of sample preparation. In 2015, Current Pharmaceutical Biotechnology will continue in this direction with quality papers that can be expected to trigger further investigations.

Drs. Eric Betzig and William E. Moerner also developed methods and biotechniques which have enabled the study of single molecules in ongoing chemical reactions in living cells. Because now it is possible to see individual macromolecules moving about in a living cell, we can study chemistry at a single-molecule level and in real life. And this is very important to chemistry because chemistry has traditionally been about studying a large number of molecules and the effect that they have. The journal Current Pharmaceutical Biotechnology has published on this research and has been at the forefront for over more than one decade. Curr. Pharm. Biotechnol. has published thematic issues, original research and review articles about the entirely new possibilities for chemistry and for biochemistry by eminent scientists from around the world, some examples:

Editor's Choice

Species Specificity on Interaction between IgE and FcεRI

, 2019; 20(9): 690 - 695

Xiangsheng Li, Nannan Wang, Yang Zhao, Yanfen Zhang* and Zhongcheng Liu*


DOI: 10.2174/1389201020666190619122325



Expanding the Biotherapeutics Realm via miR-34a: “Potent Clever Little” Agent in Breast Cancer Therapy

, 2019; 20(8): 665 - 673

Mohsen Mohammady, Seyed I. Ghetmiri, Mahtab Baharizade, Mohammad H. Morowvat* and Susan Torabi


DOI: 10.2174/1389201020666190617162042




Tuberculosis: Current Status, Diagnosis, Treatment and Development of Novel Vaccines

, 2019; 20(6): 446 - 458

Jyoti Yadav, Sonali Verma, Darshna Chaudhary, Pawan K. Jaiwal and Ranjana Jaiwal*


DOI: 10.2174/1389201020666190430114121



Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway

, 2019; 20(5): 422 - 432

Yu-lin Tan, Han-xiao Ou, Min Zhang, Duo Gong, Zhen-wang Zhao, Ling-yan Chen, Xiao-dan Xia, Zhong-cheng Mo* and Chao-ke Tang*


DOI: 10.2174/1389201020666190404125213





Downregulation of TdT Expression through Splicing Modulation by Antisense Peptide Nucleic Acid (PNA)

, 2019; 20(2): 168 - 178

Soheila Montazersaheb, Masoumeh Kazemi, Elahe Nabat, Peter E. Nielsen* and Mohammad S. Hejazi*


DOI: 10.2174/1389201020666190206202650




The Role of Extracellular Nucleic Acids in Rheumatoid Arthritis

, 2018; 19(15): 1182 - 1188

Elena Neumann*, Rebecca Hasseli, Uwe Lange and Ulf Müller-Ladner


DOI: 10.2174/1389201020666190102150216



Open Access Articles

Does Nimodipine, a Selective Calcium Channel Blocker, Impair Chondrocyte Proliferation or Damage Extracellular Matrix Structures?

, 2019; 20(6): 517 - 524

Necati Kaplan, Ibrahim Yilmaz, Numan Karaarslan*, Yasin E. Kaya, Duygu Y. Sirin and Hanefi Ozbek




Evaluation of Changes in the Expression Pattern of EDIL3 in Different Grades of Endometrial Cancer

, 2019; 20(6): 483 - 488

Marcin Oplawski*, Konrad Dziobek, Nikola Zmarzły, Beniamin Grabarek, Barbara Tomala, Ewa Leśniak, Iwona Adwent, Piotr Januszyk, Dariusz Dąbruś and Dariusz Boroń




Fenoldopam Mesylate: A Narrative Review of Its Use in Acute Kidney Injury

, 2019; 20(5): 366 - 375

Annalisa Noce*, Giulia Marrone, Valentina Rovella, Andrea Busca, Caterina Gola, Michele Ferrannini and Nicola Di Daniele*




Expression of NRP-1 and NRP-2 in Endometrial Cancer

, 2019; 20(3): 254 - 260

Marcin Oplawski*, Konrad Dziobek, Beniamin Grabarek, Nikola Zmarzły, Dariusz Dąbruś, Piotr Januszyk, Ryszard Brus, Barbara Tomala and Dariusz Boroń




Gender Difference Response of Male and Female Immunodeficiency Rats Treated with Tissue-specific Biomolecules

, 2019; 20(3): 245 - 253

Liliya V. Fedulova, Alexandr A. Basov, Ekaterina R. Vasilevskaya and Stepan S. Dzhimak*




Effect of Powdered Activated Carbon as Advanced Step in Wastewater Treatments on Antibiotic Resistant Microorganisms

, 2019; 20(1): 63 - 75

Damiana Ravasi, Roger König, Pamela Principi, Giuseppe Perale and Antonella Demarta*





Expression Profile of Endoglin in Different Grades of Endometrial Cancer

, 2018; 19(12): 990 - 995

Marcin Opławski*, Konrad Dziobek, Iwona Adwent, Dariusz Dąbruś, Beniamin Grabarek, Nikola Zmarzły, Andrzej Plewka and Dariusz Boroń




Enzymatic Hydrolysis of Hyaluronic Layer before Drug Dosing

, 2018; 19(12): 963 - 972

Anna Trusek*, Anita Niesobska and Damian Semba





Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma

, 2018; 19(8): 611 - 621

Ryan L. Setten, Helen L. Lightfoot, Nagy A. Habib and John J. Rossi*





Verification between Original and Biosimilar Therapeutic Antibody Infliximab Using nSMOL Coupled LC-MS Bioanalysis in Human Serum

, 2018; 19(6): 495 - 505

Noriko Iwamoto, Kotoko Yokoyama, Megumi Takanashi, Atsushi Yonezawa, Kazuo Matsubara and Takashi Shimada*





Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances

, 2018; 19(2): 91 - 98

Claude Guillou*, Fabiano Reniero, Joana Lobo Vicente, Margaret Holland, Kamil Kolar, Hubert Chassaigne, Salvatore Tirendi and Herve Schepers





Most Cited Articles

Review Article

Car T-cell therapy: A new era in cancer immunotherapy

, 2018; 19(1): 5-18.

Miliotou N. Androulla and Papadopoulou C. Lefkothea*


DOI: 10.2174/1389201019666180418095526



Review Article

Naringenin and its nano-formulations for fatty liver: Cellular modes of action and clinical perspective

, 2018; 19(3): 196-205.

Mehdi Zobeiri, Tarun Belwal, Fatemeh Parvizi, Rozita Naseri, Mohammad H. Farzaei*, Seyed F. Nabavi, Antoni Sureda and Seyed M. Nabavi


DOI: 10.2174/1389201019666180514170122


Review Article

Analytical approaches in fatal intoxication cases involving new synthetic opioids

, 2018; 19(2): 113-123.

Enrico Gerace*, Alberto Salomone and Marco Vincenti


DOI: 10.2174/1389201019666180405162734



General Review Article

Recent progress and future perspectives of antibiofilm drugs immobilized on nanomaterials

, 2018; 19(8): 631-643.

Fazlurrahman Khan, Mohammad M. Khan and Young-Mog Kim*


DOI: 10.2174/1389201019666180828090052




General Review Article

Apoptosis: Mediator molecules, interplay with other cell death processes and therapeutic potentials

, 2018; 19(8): 644-663.

Jiban Barman, Ritesh Kumar, Gundappa Saha, Kartikeya Tiwari and Vikash K. Dubey*


DOI: 10.2174/1389201019666180821093239



Review Article

Intestinal crosstalk between microbiota and serotonin and its impact on gut motility

, 2018; 19(3): 190-195.

Xiaolong Ge, Junhai Pan, Yichang Liu, Hongkan Wang, Wei Zhou* and Xianfa Wang


DOI: 10.2174/1389201019666180528094202



Research Article

Changes in the expression profile of JAK/STAT signaling pathway genes and mirnas regulating their expression under the adalimumab therapy

, 2018; 19(7): 556-565.

Beniamin Grabarek, Dominika Wcislo-Dziadecka*, Joanna Gola, Celina Kruszniewska-Rajs, Ligia Brzezinska-Wcislo, Nikola Zmarzly and Urszula Mazurek


DOI: 10.2174/1389201019666180730094046


Review Article

Development of MTL-CEBPA: Small activating RNA drug for hepatocellular carcinoma

, 2018; 19(8): 611-621.

Ryan L. Setten, Helen L. Lightfoot, Nagy A. Habib and John J. Rossi*


DOI: 10.2174/1389201019666180611093428




Most Accessed Articles

CAR T-cell Therapy: A New Era in Cancer Immunotherapy

, 2018; 19(1): 5-18.

Androulla N. Miliotou and Lefkothea C. Papadopoulou*


DOI: 10.2174/1389201019666180418095526



HELLP Syndrome: Pathophysiology and Current Therapies

, 2018; 19(10): 816-826.

Kedra Wallace*, Sharonda Harris, Augustina Addison and Cynthia Bean


DOI: 10.2174/1389201019666180712115215






Tuberculosis: Current Status, Diagnosis, Treatment and Development of Novel Vaccines

, 2019; 20(6): 446-458.

Jyoti Yadav, Sonali Verma, Darshna Chaudhary, Pawan K. Jaiwal and Ranjana Jaiwal*


DOI: 10.2174/1389201020666190430114121


Expression of NRP-1 and NRP-2 in Endometrial Cancer

, 2019; 20(3): 254-260.

Marcin Oplawski*, Konrad Dziobek, Beniamin Grabarek, Nikola Zmarzły, Dariusz Dąbruś, Piotr Januszyk, Ryszard Brus, Barbara Tomala and Dariusz Boroń


DOI: 10.2174/1389201020666190219121602




Editor-in-Chief

Davide Prosperi
Department of Biotechnology and Bioscience
University of Milano-Bicocca
Milano
Italy

Biography View Full Editorial Board

Journal History

Current Pharmaceutical Biotechnology was launched in 2000. Dr. Davide Prosperi serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Related Journals

Related eBooks

eBooks Catalog